[HTML][HTML] Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for cardiovascular disease in clinical practice: A randomized, open-label …
AS Binbrek, A Elis, M Al-Zaibag, J Eha, I Keber… - Current therapeutic …, 2006 - Elsevier
BACKGROUND:: The majority of clinical trials investigating the clinical benefits of lipid-
lowering therapies (LLTs) have focused on North American or western and nothern …
lowering therapies (LLTs) have focused on North American or western and nothern …
[PDF][PDF] Rosuvastatin Versus Atorvastatin in Achieving Lipid Goals in Patients at High Risk for Cardiovascular Disease in Clinical Practice: A Randomized, Open-Label …
AS Binbrek, MD Avishay Elis, AIZ Muayed - 2006 - cyberleninka.org
Background: The majority of clinical trials investigating the clinical benefits of lipid-lowering
therapies (LLTs) have focused on North American or western and nothern European …
therapies (LLTs) have focused on North American or western and nothern European …
Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for cardiovascular disease in clinical practice: A randomized, open-label, parallel …
AS Binbrek, A Elis, M Al-Zaibag, J Eha, I Keber… - Current Therapeutic …, 2006 - infona.pl
The majority of clinical trials investigating the clinical benefits of lipid-lowering therapies
(LLTs) have focused on North American or western and nothern European populations …
(LLTs) have focused on North American or western and nothern European populations …
[PDF][PDF] Rosuvastatin Versus Atorvastatin in Achieving Lipid Goals in Patients at High Risk for Cardiovascular Disease in Clinical Practice: A Randomized, Open-Label …
AS Binbrek, MD Avishay Elis, AIZ Muayed - 2006 - core.ac.uk
Background: The majority of clinical trials investigating the clinical benefits of lipid-lowering
therapies (LLTs) have focused on North American or western and nothern European …
therapies (LLTs) have focused on North American or western and nothern European …
Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for cardiovascular disease in clinical practice: A randomized, open-label, parallel …
AS Binbrek, A Elis, M Al-Zaibag… - Current therapeutic …, 2006 - pubmed.ncbi.nlm.nih.gov
Background The majority of clinical trials investigating the clinical benefits of lipid-lowering
therapies (LLTs) have focused on North American or western and nothern European …
therapies (LLTs) have focused on North American or western and nothern European …
Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for cardiovascular disease in clinical practice: A randomized, open-label, parallel …
AS Binbrek, A Elis, M Al-Zaibag, J Eha… - Current Therapeutic …, 2006 - europepmc.org
Background The majority of clinical trials investigating the clinical benefits of lipid-lowering
therapies (LLTs) have focused on North American or western and nothern European …
therapies (LLTs) have focused on North American or western and nothern European …
[HTML][HTML] Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for cardiovascular disease in clinical practice: A randomized, open-label …
AS Binbrek, A Elis, M Al-Zaibag, J Eha… - Current Therapeutic …, 2006 - ncbi.nlm.nih.gov
Background: The majority of clinical trials investigating the clinical benefits of lipid-lowering
therapies (LLTs) have focused on North American or western and nothern European …
therapies (LLTs) have focused on North American or western and nothern European …
[引用][C] Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for cardiovascular disease in clinical practice: A randomized, open-label, parallel …
AS BINBREK, A ELIS, M AL-ZAIBAG… - Current therapeutic …, 2006 - pascal-francis.inist.fr
Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for
cardiovascular disease in clinical practice : A randomized, open-label, parallel-group …
cardiovascular disease in clinical practice : A randomized, open-label, parallel-group …
Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for cardiovascular disease in clinical practice: A randomized, open-label, parallel …
AS Binbrek, A Elis, M Al-Zaibag, J Eha… - Current Therapeutic …, 2006 - europepmc.org
Background The majority of clinical trials investigating the clinical benefits of lipid-lowering
therapies (LLTs) have focused on North American or western and nothern European …
therapies (LLTs) have focused on North American or western and nothern European …